{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-073736","form_type":"8-K","ticker":"IRWD","cik":"0001446847","company_name":"IRONWOOD PHARMACEUTICALS INC","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.457192+00:00","generated_at":"2026-06-01T02:47:52.478310+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Ironwood shareholders elect nine directors, approve executive pay, ratify auditor at 2024 annual meeting","bullets":["All nine director nominees elected with over 130 million votes each for a one-year term.","Advisory vote on executive compensation passed with ~127.4 million for, ~8.0 million against.","Ratification of Ernst & Young as auditor for 2024 approved with ~136.8 million for, ~6.3 million against.","Meeting held June 18, 2024; all proposals received majority support."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-073736","json":"https://secwatch.observer/filing/0001104659-24-073736.json","markdown":"https://secwatch.observer/filing/0001104659-24-073736.md","text":"https://secwatch.observer/filing/0001104659-24-073736.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446847/000110465924073736/0001104659-24-073736-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446847/000110465924073736/tm2417654d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:47:52.478310+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}